Gleason AM, Tayebi N, Lopez GJ, Sidransky E, et al. Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease". Mov Disord 2022;37:1781-1782.
PMID: 35980034